These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35246636)

  • 1. Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits.
    Reinwald JR; Gass N; Mallien AS; Sartorius A; Becker R; Sack M; Falfan-Melgoza C; Clemm von Hohenberg C; Leo D; Pfeiffer N; Middelman A; Meyer-Lindenberg A; Homberg JR; Weber-Fahr W; Gass P
    Mol Psychiatry; 2022 Apr; 27(4):2329-2339. PubMed ID: 35246636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
    Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
    J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system.
    Adinolfi A; Zelli S; Leo D; Carbone C; Mus L; Illiano P; Alleva E; Gainetdinov RR; Adriani W
    Behav Brain Res; 2019 Feb; 359():516-527. PubMed ID: 30472113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
    Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.
    Ptukha M; Fesenko Z; Belskaya A; Gromova A; Pelevin A; Kurzina N; Gainetdinov RR; Volnova A
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
    Fox MA; Panessiti MG; Hall FS; Uhl GR; Murphy DL
    Psychopharmacology (Berl); 2013 Jun; 227(4):685-95. PubMed ID: 23417514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons.
    Berlanga ML; Price DL; Phung BS; Giuly R; Terada M; Yamada N; Cyr M; Caron MG; Laakso A; Martone ME; Ellisman MH
    Brain Res; 2011 May; 1390():41-9. PubMed ID: 21439946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
    Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
    J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
    J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novelty-related behavior of young and adult dopamine transporter knockout rats: Implication for cognitive and emotional phenotypic patterns.
    Adinolfi A; Carbone C; Leo D; Gainetdinov RR; Laviola G; Adriani W
    Genes Brain Behav; 2018 Apr; 17(4):e12463. PubMed ID: 29406596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.
    Adriani W; Koot S; Columba-Cabezas S; Romano E; Travaglini D; van den Bos R; Granstrem O; Ali SF; Laviola G
    Behav Brain Funct; 2012 Nov; 8():54. PubMed ID: 23192105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice.
    Carpenter AC; Saborido TP; Stanwood GD
    Dev Neurosci; 2012; 34(2-3):250-7. PubMed ID: 22572477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADHD and the dopamine transporter: are there reasons to pay attention?
    Mazei-Robinson MS; Blakely RD
    Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia.
    Cinque S; Zoratto F; Poleggi A; Leo D; Cerniglia L; Cimino S; Tambelli R; Alleva E; Gainetdinov RR; Laviola G; Adriani W
    Front Psychiatry; 2018; 9():43. PubMed ID: 29520239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered neurocircuitry in the dopamine transporter knockout mouse brain.
    Zhang X; Bearer EL; Boulat B; Hall FS; Uhl GR; Jacobs RE
    PLoS One; 2010 Jul; 5(7):e11506. PubMed ID: 20634895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.